NO982582L - Procedure for the treatment of pain - Google Patents

Procedure for the treatment of pain

Info

Publication number
NO982582L
NO982582L NO982582A NO982582A NO982582L NO 982582 L NO982582 L NO 982582L NO 982582 A NO982582 A NO 982582A NO 982582 A NO982582 A NO 982582A NO 982582 L NO982582 L NO 982582L
Authority
NO
Norway
Prior art keywords
pain
procedure
treatment
composition
compound
Prior art date
Application number
NO982582A
Other languages
Norwegian (no)
Other versions
NO982582D0 (en
Inventor
Charles H Mitch
Harlan E Shannon
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO982582D0 publication Critical patent/NO982582D0/en
Publication of NO982582L publication Critical patent/NO982582L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Processing Of Meat And Fish (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Foreliggende oppfinnelse fremskaffer en fremgangsmåte og en sammensetning for behandling av smerte ved anvendelse av en sammensetning omfattende en azabicyklisk eller tetrahydropyridinforbindelse og en klassisk analgesisk forbindelse.The present invention provides a method and composition for treating pain using a composition comprising an azabicyclic or tetrahydropyridine compound and a classical analgesic compound.

NO982582A 1995-12-07 1998-06-05 Procedure for the treatment of pain NO982582L (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US829895P 1995-12-07 1995-12-07
US831995P 1995-12-07 1995-12-07
US830695P 1995-12-07 1995-12-07
US829595P 1995-12-07 1995-12-07
US831395P 1995-12-07 1995-12-07
US831295P 1995-12-07 1995-12-07
US831895P 1995-12-07 1995-12-07
PCT/US1996/019390 WO1997020556A1 (en) 1995-12-07 1996-12-05 Method for treating pain

Publications (2)

Publication Number Publication Date
NO982582D0 NO982582D0 (en) 1998-06-05
NO982582L true NO982582L (en) 1998-08-03

Family

ID=27567403

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982582A NO982582L (en) 1995-12-07 1998-06-05 Procedure for the treatment of pain

Country Status (14)

Country Link
EP (1) EP0866702A4 (en)
JP (1) JP2000501711A (en)
KR (1) KR19990071977A (en)
CN (1) CN1208348A (en)
AU (1) AU715645B2 (en)
CA (1) CA2239732A1 (en)
CZ (1) CZ174598A3 (en)
EA (1) EA199800535A1 (en)
HU (1) HUP0000110A3 (en)
IL (1) IL124786A0 (en)
NO (1) NO982582L (en)
NZ (1) NZ324594A (en)
PL (1) PL327144A1 (en)
WO (1) WO1997020556A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6559171B1 (en) 1999-06-04 2003-05-06 Eli Lilly And Company 7-oxo-2-azabicyclo[2.2.1]heptanes as selective muscarinic receptor antagonist
WO2015023675A2 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
CA2955229C (en) 2014-07-17 2020-03-10 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
JP2017531026A (en) 2014-10-20 2017-10-19 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド Sustained release abuse deterrent liquid filler form
WO2021097427A1 (en) 2019-11-15 2021-05-20 Karuna Therapeutics, Inc. Xanomeline derivatives and methods for treating neurological disorders
CN115974863A (en) * 2021-10-14 2023-04-18 南京迈诺威医药科技有限公司 Malate of xanomeline derivative, crystal form A, preparation method of malate, and application of crystal form A

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
US5376668A (en) * 1990-08-21 1994-12-27 Novo Nordisk A/S Heterocyclic compounds
DK198590D0 (en) * 1990-08-21 1990-08-21 Novo Nordisk As HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND USE
US5527813A (en) * 1990-08-21 1996-06-18 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
WO1993014089A1 (en) * 1992-01-13 1993-07-22 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
US5605701A (en) * 1995-02-17 1997-02-25 Eli Lilly And Company Transdermal formulation

Also Published As

Publication number Publication date
HUP0000110A3 (en) 2000-09-28
CA2239732A1 (en) 1997-06-12
HUP0000110A2 (en) 2000-06-28
EP0866702A1 (en) 1998-09-30
KR19990071977A (en) 1999-09-27
AU715645B2 (en) 2000-02-10
JP2000501711A (en) 2000-02-15
CZ174598A3 (en) 1999-01-13
WO1997020556A1 (en) 1997-06-12
CN1208348A (en) 1999-02-17
EA199800535A1 (en) 1998-12-24
IL124786A0 (en) 1999-01-26
AU1147697A (en) 1997-06-27
PL327144A1 (en) 1998-11-23
EP0866702A4 (en) 2001-07-25
NO982582D0 (en) 1998-06-05
NZ324594A (en) 1999-09-29

Similar Documents

Publication Publication Date Title
NO974378D0 (en) Process for the treatment of gases
NO981810D0 (en) Compositions and Methods for Treating Bone Failure Conditions
EA200100572A1 (en) METHOD OF APPLICATION OF CYCLOOXIGENASE-2 INHIBITOR AND ONE OR MULTIPLE ANTITUMOR MEDICINES AS A COMBINED METHOD OF MEDICAL EXPOSURE IN THE TREATMENT OF NEOPLASIA
UA26213C2 (en) MEANS FOR PREVENTION AND TREATMENT OF OSTEOPOROSIS AND PHARMACEUTICAL COMPOSITION AND THEIR BASES
BR9604959A (en) Composition and method for the treatment of tooth desensitization
DE69805973T2 (en) TREATING HEART CRYSTAL DISORDERS BY INHIBITING A MULTIFUNCTIONAL CALCIUM / CALMODULIN-DEPENDENT PROTEIN KINASE
NO963322D0 (en) Procedure for the treatment of abstinence in substance abuse
DE69603089T2 (en) COMPOSITION FOR TREATING MASONRY
NO962482D0 (en) Apparatus and method for the treatment of organohalogenic compounds
MX9401294A (en) DERIVATIVES OF SUBSTITUTED AZOLONA
DK91793A (en) Method of surface treatment, means of application and its use
EE9700198A (en) Method and apparatus for the treatment of organic waste
DE69405919D1 (en) Compositions for the treatment of keratin fibers
NO982582L (en) Procedure for the treatment of pain
DE69626311T2 (en) COMPOSITION FOR THE TREATMENT OF LAUNDRY AND METHOD THEREFOR
IL143516A0 (en) COMPOUNDS AND METHODS FOR MODULATING ACTIVATION OF NF-k-B
MY115046A (en) Medicinal composition for diabetes
ATE283920T1 (en) METHOD FOR IMMUNIZATION AND TREATMENT OF H. PYLORI INFECTION
DE69717846D1 (en) TREATMENT METHOD OF LACTATAS
NO973366L (en) Procedure for the treatment of multiple sclerosis
NO982562L (en) Composition for the treatment of pain
DE69412178D1 (en) Device for the treatment of layers
NO990436L (en) Procedure for the treatment of bipolar disorder
NO984196L (en) Procedure for the treatment of substance abuse
NO984198L (en) Procedure for the treatment of aggression